Compare INSP & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSP | IART |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2018 | 1996 |
| Metric | INSP | IART |
|---|---|---|
| Price | $43.45 | $18.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 7 |
| Target Price | ★ $94.00 | $14.33 |
| AVG Volume (30 Days) | 822.0K | ★ 871.9K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 179.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,050,000.00 | N/A |
| Revenue This Year | $8.02 | $4.39 |
| Revenue Next Year | $8.11 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 62.18 | N/A |
| 52 Week Low | $38.91 | $8.70 |
| 52 Week High | $147.03 | $18.30 |
| Indicator | INSP | IART |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 66.33 |
| Support Level | $39.26 | $10.61 |
| Resistance Level | $44.75 | N/A |
| Average True Range (ATR) | 1.99 | 0.75 |
| MACD | 0.49 | -0.11 |
| Stochastic Oscillator | 71.25 | 69.66 |
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.